Hyundai Glovis Wins Certification For Healthcare Logistics
Hyundai Glovis, a logistical company in South Korea that’s part of the Hyundai Kia Automotive Group, has recently won international certification for healthcare logistics, giving them the necessary licensing needed to operate as a medical logistics company, and make their break into the global healthcare logistics market.
The company announced on Dec. 7, that it recently acquired the ISO 13485 certification from the British Standards Institute (BSI) on the day prior.
ISO 13495 is an international standard that was established by the International Organization for Standardization (ISO), the international standard-setting body comprised of representatives from across the world. Any company that possesses the ISO 13485 certification means that that company’s quality control system for medical equipment management meets the internationally-recognized standards and complies with all the rules and policies that are associated with ISO 13485. This certification is needed for logistics firms to operate as a medical logistics company, provide services related to medical devices across the world.
Hyundai Glovis, having finally earned their ISO 13485 registration, are set to enter the global healthcare logistics market. Reportedly, Glovis plans to take an aggressive stance in the market, which has been led by international companies, like DHL and FedEx.
In the healthcare logistics field, demand for air transport has seen a decline, thanks to healthcare technology producers are, instead, opting for sea transport in order to cut down on logistics costs.
According to a company official, Hyundai Glovis will work towards establishing itself as a global logistics business specializing healthcare based on their currently existing integrated logistics system. Reportedly, they’ll be looking to find new clients in the field of biotechnology and medical technology through marketing the Hyundai Glovis brand.
Reportedly, the company also has plans to further expand its operations as a medical logistics company in the second half of 2019, via the acquisition of the KSGP Certification, a standard for quality control and medicine storage in their home country of Korea, which would let the company move into bio and clinical drug logistics.
Currently, the domestic Korean third-party logistics (3PL) market for healthcare companies centred on medical technologies and medicine sits at a total market value of about 310 billion won.